Search Results - "Ashworth, J L"

Refine Results
  1. 1

    Refractive outcomes after primary intraocular lens implantation in infants by Ashworth, J L, Maino, A P, Biswas, S, Lloyd, I C

    Published in British journal of ophthalmology (01-05-2007)
    “…Background: Intraocular lens (IOL) implantation is becoming increasingly accepted as a primary procedure in infants. Aim: To evaluate the accuracy of IOL power…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Fibrillin and the eye by ASHWORTH, JANE L, KIELTY, CAY M, McLEOD, DAVID

    Published in British journal of ophthalmology (01-11-2000)
    “…Fibrillin polymers form the structural scaffold of extensible microfibrils 1-3 which are present in ocular elastic tissues and are arranged in parallel bundles…”
    Get full text
    Journal Article Book Review
  5. 5

    Fibrillin: from microfibril assembly to biomechanical function by Kielty, C. M., Baldock, C., Lee, D., Rock, M. J., Ashworth, J. L., Shuttleworth, C. A.

    “…Fibrillins form the structural framework of a unique and essential class of extracellular microfibrils that endow dynamic connective tissues with long–range…”
    Get full text
    Journal Article
  6. 6

    Anterior segment OCT imaging in mucopolysaccharidoses type I, II, and VI by Ahmed, T Y, Turnbull, A M J, Attridge, N F, Biswas, S, Lloyd, I C, Au, L, Ashworth, J L

    Published in Eye (London) (01-03-2014)
    “…Purpose To describe the anterior segment optical coherence tomography (AS-OCT) characteristics of patients with ocular manifestations of mucopolysaccharidoses…”
    Get full text
    Journal Article
  7. 7

    The ocular features of the mucopolysaccharidoses by ASHWORTH, J. L, BISWAS, S, WRAITH, E, LLOYD, I. C

    Published in Eye (London) (01-05-2006)
    “…The mucopolysaccharidoses (MPS) are a heterogeneous group of rare disorders characterised by accumulation of glycosaminoglycans within multiple organ systems…”
    Get full text
    Journal Article
  8. 8

    Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues by A-MOHAMMADI, S, ALVAREZ-VALLINA, L, ASHWORTH, L. J, HAWKINS, R. E

    Published in Gene therapy (01-09-1997)
    “…The tetracycline-regulatable system (TRS) has become a widely adopted tool for modification of gene expression and analysis of gene function in mammalian…”
    Get full text
    Journal Article
  9. 9

    The hydroxyapatite orbital implant: A prospective study by ASHWORTH, J. L, RHATIGAN, M, SAMPATH, R, BRAMMAR, R, SUNDERLAND, S, LEATHERBARROW, B

    Published in Eye (London) (01-01-1996)
    “…The hydroxyapatite orbital implant was first released for use as an orbital implant in humans in August 1989. It has been shown to be well tolerated, providing…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis by Ferrari, Stefano, Ponzin, Diego, Ashworth, Jane L, Fahnehjelm, Kristina Teär, Summers, C Gail, Harmatz, Paul R, Scarpa, Maurizio

    Published in British journal of ophthalmology (01-05-2011)
    “…Ocular pathology is common in patients with mucopolysaccharidosis (MPS), a hereditary lysosomal storage disorder, where the eye as well as other tissues…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    A clinical study of the hydroxyapatite orbital implant by Ashworth, J L, Rhatigan, M, Brammar, R, Sunderland, S, Leatherbarrow, B

    Published in European journal of ophthalmology (01-01-1997)
    “…The hydroxyapatite orbital implant has been used in the anophthalmic patient to give good motility of the artificial eye and a cosmetic result which matches…”
    Get more information
    Journal Article
  16. 16

    Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling by Ashworth, J L, Murphy, G, Rock, M J, Sherratt, M J, Shapiro, S D, Shuttleworth, C A, Kielty, C M

    Published in Biochemical journal (15-05-1999)
    “…Fibrillin is the principal structural component of the 10-12 nm diameter elastic microfibrils of the extracellular matrix. We have previously shown that both…”
    Get full text
    Journal Article
  17. 17

    Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins by WHITTINGTON, H. A, ASHWORTH, L. I, HAWKINS, R. E

    Published in Gene therapy (01-06-1998)
    “…Antibodies and their recombinant fragments have enormous potential for therapy of malignant and other diseases, but there can be problems associated with their…”
    Get full text
    Journal Article
  18. 18

    Correction of blepharoconjunctivitis-related upper eyelid entropion using the anterior lamellar reposition technique by RHATIGAN, M. C, ASHWORTH, J. L, GOODALL, K, LEATHERBARROW, B

    Published in Eye (London) (01-01-1997)
    “…Upper eyelid entropion is a complication of chronic blepharoconjunctivitis which may be easily missed unless careful examination of the lid margin of patients…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Idiotypic DNA vaccines against B-cell lymphoma by Stevenson, F K, Zhu, D, King, C A, Ashworth, L J, Kumar, S, Hawkins, R E

    Published in Immunological reviews (01-06-1995)
    “…Idiotypic antigens are clearly defined tumor-associated protein antigens, which can induce protective immunity against lymphoma. Because each patient requires…”
    Get more information
    Journal Article